School of Medicine


Showing 1-9 of 9 Results

  • James N. Lau, MD, MHPE, FACS

    James N. Lau, MD, MHPE, FACS

    Clinical Professor, Surgery - General Surgery

    Current Research and Scholarly Interests My personal mission is to contribute to the overall care of the surgical patient through clinical practice, training, and education. My research interests, as they pertain to this mission, are the surgical management of ventral hernias, minimal access surgical techniques, evidenced based surgery, surgical skills acquisition, and surgical education.

  • Byrne Lee, MD FACS

    Byrne Lee, MD FACS

    Clinical Professor, Surgery - General Surgery

    Bio Dr. Lee is a native of New York City. He attended the Sophie Davis School of Biomedical Education at the City College of New York and received his medical degree from New York Medical College. He completed general surgery residency training at Lenox Hill Hospital and fellowship training in surgical oncology at the City of Hope National Cancer Center. Dr. Lee led the Peritoneal Surface Malignancy Program at City of Hope prior to joining Stanford in 2019.

    Dr. Lee is a surgical oncologist who specializes in the treatment of gastrointestinal malignancies. He has dedicated his clinical practice to the surgical management of metastatic disease, particularly to the liver and peritoneum. He has expertise in delivering regional cancer therapies such as heated intraperitoneal chemotherapy (HIPEC). Additionally, he performs surgery for cancers of the stomach, liver, pancreas, small intestine, colon, and soft tissue sarcoma. He utilizes minimally invasive and robotic surgical techniques when appropriate.

    Dr. Lee leads the Regional Cancer Therapies program at Stanford. The program implements and develops novel treatment strategies for patients affected with peritoneal malignancies and oligometastatic disease to the liver. His research focus is on clinical outcomes of multidisciplinary management for gastric, hepatobiliary, and peritoneal surface malignancies. He is a member of a national consensus group performing collaborative research and developing clinical trials for HIPEC surgeries.

  • April Leyson

    April Leyson

    Adm Assoc 3, Surgery - General Surgery

    Current Role at Stanford Administrative Associate
    For Drs. John M. Morton, Dan E. Azagury,
    Yulia Zak, and George Poultsides
    Stanford Department of Surgery
    Section of Bariatric and Minimally Invasive Surgery

  • Dana Lin, MD

    Dana Lin, MD

    Clinical Assistant Professor, Surgery - General Surgery

    Bio Dr. Lin is a fellowship-trained endocrine surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. After receiving her undergraduate degree from Stanford University, Dr. Lin pursued her medical and surgical training on the east coast, where she completed her residency in general surgery at Rutgers Robert Wood Johnson Medical School and fellowship in endocrine surgery at the Harvard-affiliated Massachusetts General Hospital.

    Dr. Lin's clinical practice focuses on the surgical management of benign and malignant thyroid conditions, hyperparathyroidism, adrenal tumors, as well as melanoma and advanced skin cancers. She is skilled in mini-incision, minimally invasive (laparoscopic), and remote access (scarless endoscopic) surgery as well as lymph node dissection for cancer. She currently serves as Director of the Parathyroid Center within the Endocrine Oncology Program at Stanford.

    Dr. Lin strives to deliver expert surgical care to patients with utmost humanism and compassion. She considers it a privilege and joy to be entrusted as one?s surgeon and is committed to ensuring the best clinical and cosmetic outcome for each of her patients. Dr. Lin welcomes patients at Stanford Cancer Center in Palo Alto as well as Stanford Health Care in Emeryville and Pleasanton (ValleyCare).

  • Daphne P. Ly, MD, FACS

    Daphne P. Ly, MD, FACS

    Clinical Associate Professor, Surgery - General Surgery

    Current Research and Scholarly Interests 1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
    2. Apply Cancer Genetics in cancer treatment and cancer risk reduction.

Footer Links:

Stanford Medicine Resources: